Study details
Enrolling now
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
University of Cincinnati
NCT IDNCT06416007ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
37
Study length
about 2.8 years
Ages
18+
Locations
1 site in OH
About this study
Researchers are testing if lattice radiation therapy (LRT) can provide better treatment for bulky tumors than current standard radiotherapy. The trial will involve 37 patients receiving 5 fractions of LRT every other day over a period of approximately 10 months. The main goals are to see how well LRT works and what side effects occur.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Lattice therapy (LRT)
PhasePhase 2
Primary goalAdverse Events
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Adverse Events, Overall Response Rate
Secondary: Overall Survival, Patient-reported Quality of Life
Body systems
Oncology